10 Stocks That Are Screaming Buys Right Now

Social media giant Facebook (NASDAQ:FB) is one of the best stocks to invest in right now. Shares are cheap at $203. And now we have a clear buying opportunity on our hands according to two top analysts. Five-star MKM Partners analyst Rob Sanderson says FB’s current valuation is “highly attractive.” Shares have pulled back as investors “debate the impact of an expected decline in engagement, revenue growth deceleration and an elevated spending outlook.” With another strong quarter of robust top-line growth in the bank, Sanderson sees prices spiking 17% to $240.

Boeing (BA): One of the world’s largest aerospace companies, shares in Boeing (NYSE:BA) slipped this year on trade war fears. But Head of Research at Fundstrat Tom Lee believes the market overreacted. He has calculated that Boeing actually has a trade war exposure of just 35.2%. To calculate this figure, Lee looked at the company’s overseas sourcing as a percentage of cost of goods sold and exports as a percentage of sales. A percentage under 40% means the company has a low trade war exposure, according to Lee.

Alexion Pharmaceuticals (ALXN): Alexion Pharmaceuticals (NASDAQ:ALXN) is a U.S. pharma company best known for its development of Soliris, a drug used to treat rare blood disorders. In total, Alexion has scored eight buy ratings and only one hold rating from best-performing analysts in the past three months. These analysts predict that Alexion will rise roughly 33% to reach $153.

Pioneer Natural (PXD): Texas-based Pioneer Natural Resources (NYSE:PXD) is on the cusp of great things. The company is divesting all non-Permian assets. This asset sale should raise PXD about $1 billion and it transforms PXD into a pure-play on the Permian Basin. Given that this is one of the world’s most lucrative oil fields, that’s no bad thing. B. Riley FBR analyst Rehan Rashid applauds the company’s “strategic realignment.” He says the move will enable PXD to ramp up its investment in its Permian assets. “We believe this platform and the substantial resource base it has to offer are simply not replicable. We reiterate our Buy rating and $305 price target and add PXD to the B. Riley FBR Alpha Generator list” says Rashid. He calculates “new” resource potential of nearly 20 billion BOE (barrels of oil or equivalent). TipRanks shows that Pioneer has received 13 buy ratings and three hold ratings from top analysts. Given that the stock is now at $185, analysts are projecting (on average) upside potential of 27%.

Vertex Pharmaceuticals (VRTX) Global biotech stock Vertex Pharmaceuticals (NASDAQ:VRTX) is a prime investing pick right now with a growing portfolio of cystic fibrosis (CF) drugs. This is a genetic disorder that causes severe damage to the lungs, digestive system and other organs in the body.
The company scored a key approval from the FDA for its third CF drug, Symdeko, earlier this year. The approval came two weeks earlier than expected and “potentially speaks to the FDA’s growing comfort with the suite of VRTX medicines” says JP Morgan’s Cory Kasimov. Management is now anticipating a “strong launch” for Symdeko with E.U. approval on track for the second half of 2018. Overall, this “strong buy” stock scored 12 top buy ratings and just one hold ratings in the past few months. Meanwhile, the average analyst price target of $187 works out to 8% upside from current share levels.

Raytheon (RTN) Defense giant Raytheon Company (NYSE:RTN) is the world’s largest producer of guided missiles. As with Boeing, you may be concerned that this stock would suffer in the event of a trade war. However, you can rest easy. According to research firm Fundstrat, it actually has a trade-war exposure percentage of 35.2% (again, anything under 40% is considered low). And from a Street perspective, the outlook on RTN is also very bullish right now.

Alibaba (BABA): Chinese e-commerce giant Alibaba (NYSE:BABA) has a “moderate buy” analyst consensus rating with big upside potential of 30%. The Street is unanimous in its take on BABA as one of the best stocks to invest in right now. I say that because in the last ten months, this stock has received no hold or sell ratings from the Street. Just 100% buy ratings.

Skechers (NYSE:SKX) is primed for significant expansion. Even after a 60% rise last year, the company remains notably undervalued compared to its athletic retail peers. Top Susquehanna analyst Sam Poser recently reiterated a target of $40. The new target indicates a further 34% upside from the current share price. In the last three months, Skechers has received five buys and one hold, and an average price target of $42.67.

2U Inc (TWOU): Online education platform 2U (NASDAQ:TWOU) received a slew of price target increases from the Street this year. On May 3, the company reported Q4 results ahead of expectations. This marks its 16th consecutive quarter of outperformance. 2U’s Q4 organic revenue growth accelerated to about 30% year-over-year, and 2018 guidance implies another year of “Tier 1” industry revenue growth. But for top Oppenheimer analyst Brian Schwartz it’s not just about 2018 — it’s about the changes sweeping through the education industry. He sees a “high migration” likelihood toward the digital channel for students and learning over the next decade.

MasTec (MTZ): Last but not least of all the best stocks to invest in for 2018, we have Florida-based specialty contractor engineer MasTec (NYSE:MTZ). The company’s work spans electric power infrastructure, oil and natural gas pipelines, renewable energy facilities and wireless networks. Strength across the board has resulted in 100% Street support with four top analysts publishing recent buy ratings. These analysts spy 16% upside potential for MTZ.

Read more:

• DAX continues consolidate
• Sodexo – Breakthrough the short trend channel and forming a new upward trend
• Norma Group (NOJ): Breakthrough a key resistance zone
• Capita PLC: Inverted head activated, for increace
• Canopy Growth Corporation (CGC) Breakthrough the bearish channel, possible long